Incidence and risk factors for chemotherapy-induced nausea or vomiting following highly or moderately emetogenic chemotherapy in community oncology practice-Reference-Cited by-同舟云学术

Incidence and risk factors for chemotherapy-induced nausea or vomiting following highly or moderately emetogenic chemotherapy in community oncology practice

Published:2010-08 Issue:8 Volume:7 Page:347-354
ISSN:1548-5315
Container-title:Community Oncology
language:en
Short-container-title:Community Oncology

Author:

Feinberg Bruce A.,Gilmore James W.,Haislip Sally,Wentworth Charles,Burke Thomas A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference25 articles.

1. On the receiving end. V: Patient perceptions of the side effects of chemotherapy in 1993;Griffin;Ann Oncol,1996

2. Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings;Cohen;Support Care Cancer,2007

3. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment;Bloechl-Daum;J Clin Oncol,2006

4. Data-driven medical decision-making in managing chemotherapy-induced nausea and vomiting;Feinberg;Commun Oncol,2009

5. Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy;Tina Shih;Cancer,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative review of factors related to the nursing diagnosis nausea during antineoplastic chemotherapy;Revista Latino-Americana de Enfermagem;2016

2. Antiemetic Guideline Consistency and Incidence of Chemotherapy-Induced Nausea and Vomiting in US Community Oncology Practice: INSPIRE Study;Journal of Oncology Practice;2014-01